Climb Bio, Inc.
Climb Bio, Inc.（CLYM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
clym · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$35.00
Consensus
$21.88
+103.2% upside
Low
$17.00
Median: $20.5 · Last Close: $10.77
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$21.88
103.2% upside
High Target
$35
225.0%
Low Target
$17
57.8%
Current Price
$10.77
as of today
Based on analyst price targets, the CLYM stock price prediction for the next 12 months ranges from $17 to $35. The consensus CLYM price forecast of $21.88 implies 103.2% upside from the current price of $10.77.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $10.60 | ↓ 1.59% |
1-day model range: $10.49–$10.71. Peak: $10.71 (-1.59%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -28.1% |
| 2028 | $7 | -39.2% |
| 2029 | $6 | -44.3% |
| 2030 | $6 | -46.9% |
| 2031 | — | -48.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLYM · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-04-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-04-08 | BTIG | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-06 | Baird | Maintains | Outperform→Outperform |
| 2026-03-06 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-16 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Climb Bio, Inc. (CLYM) stock. Of the recent 12 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover CLYM.
分析师推荐趋势
CLYM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$1M
EPS This Year
$-0.88
EPS Next Year
$-1.06
↑ 20.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLYM EPS of $-0.88 for the current fiscal year, based on estimates from 10 analysts. The CLYM revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CLYM 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CLYM 的共识目标价为 $21.88（+103.2% 上行空间），分析师共识为 Buy。
CLYM 的短期预测（明日）为 $10.60（-1.59%）。 CLYM 对 2027 年的股价预测均值为 $8。 CLYM 对 2030 年的预测区间为 $5–$6。
Climb Bio, Inc. 在 NASDAQ 上市，代码 CLYM。CLYM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CLYM 预测 · 8 个问题根据 5 位华尔街分析师，CLYM 的 12 个月平均目标价为 $21.88，最高 $35.00、最低 $17.00。若有图表，中位目标价可在上方查看。相对当前价 $10.77，隐含约 +103.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.